1 Study Coverage
    1.1 Specialty Active Pharmaceutical Ingredients Product Introduction
    1.2 Market by Type
        1.2.1 Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Steroidal API
        1.2.3 Peptide API
        1.2.4 Carbohydrate API
        1.2.5 Small Molecule API
        1.2.6 High Potency AP
    1.3 Market by Application
        1.3.1 Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 CNS
        1.3.3 Cardiovascular
        1.3.4 Genitourinary/Hormonal Drugs
        1.3.5 Rheumatology
        1.3.6 Diabetes
        1.3.7 Oncology
        1.3.8 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Specialty Active Pharmaceutical Ingredients Sales Estimates and Forecasts 2017-2028
    2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Estimates and Forecasts 2017-2028
    2.3 Global Specialty Active Pharmaceutical Ingredients Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Specialty Active Pharmaceutical Ingredients Sales by Region
        2.4.1 Global Specialty Active Pharmaceutical Ingredients Sales by Region (2017-2022)
        2.4.2 Global Sales Specialty Active Pharmaceutical Ingredients by Region (2023-2028)
    2.5 Global Specialty Active Pharmaceutical Ingredients Revenue by Region
        2.5.1 Global Specialty Active Pharmaceutical Ingredients Revenue by Region (2017-2022)
        2.5.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Specialty Active Pharmaceutical Ingredients Sales by Manufacturers
        3.1.1 Global Top Specialty Active Pharmaceutical Ingredients Manufacturers by Sales (2017-2022)
        3.1.2 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Specialty Active Pharmaceutical Ingredients in 2021
    3.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Manufacturers
        3.2.1 Global Specialty Active Pharmaceutical Ingredients Revenue by Manufacturers (2017-2022)
        3.2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Specialty Active Pharmaceutical Ingredients Revenue in 2021
    3.3 Global Specialty Active Pharmaceutical Ingredients Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Specialty Active Pharmaceutical Ingredients Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Specialty Active Pharmaceutical Ingredients Sales by Type
        4.1.1 Global Specialty Active Pharmaceutical Ingredients Historical Sales by Type (2017-2022)
        4.1.2 Global Specialty Active Pharmaceutical Ingredients Forecasted Sales by Type (2023-2028)
        4.1.3 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2028)
    4.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Type
        4.2.1 Global Specialty Active Pharmaceutical Ingredients Historical Revenue by Type (2017-2022)
        4.2.2 Global Specialty Active Pharmaceutical Ingredients Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2028)
    4.3 Global Specialty Active Pharmaceutical Ingredients Price by Type
        4.3.1 Global Specialty Active Pharmaceutical Ingredients Price by Type (2017-2022)
        4.3.2 Global Specialty Active Pharmaceutical Ingredients Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Specialty Active Pharmaceutical Ingredients Sales by Application
        5.1.1 Global Specialty Active Pharmaceutical Ingredients Historical Sales by Application (2017-2022)
        5.1.2 Global Specialty Active Pharmaceutical Ingredients Forecasted Sales by Application (2023-2028)
        5.1.3 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2028)
    5.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Application
        5.2.1 Global Specialty Active Pharmaceutical Ingredients Historical Revenue by Application (2017-2022)
        5.2.2 Global Specialty Active Pharmaceutical Ingredients Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2017-2028)
    5.3 Global Specialty Active Pharmaceutical Ingredients Price by Application
        5.3.1 Global Specialty Active Pharmaceutical Ingredients Price by Application (2017-2022)
        5.3.2 Global Specialty Active Pharmaceutical Ingredients Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Specialty Active Pharmaceutical Ingredients Market Size by Type
        6.1.1 North America Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2028)
        6.1.2 North America Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2028)
    6.2 North America Specialty Active Pharmaceutical Ingredients Market Size by Application
        6.2.1 North America Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2028)
        6.2.2 North America Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2028)
    6.3 North America Specialty Active Pharmaceutical Ingredients Market Size by Country
        6.3.1 North America Specialty Active Pharmaceutical Ingredients Sales by Country (2017-2028)
        6.3.2 North America Specialty Active Pharmaceutical Ingredients Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Specialty Active Pharmaceutical Ingredients Market Size by Type
        7.1.1 Europe Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2028)
        7.1.2 Europe Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2028)
    7.2 Europe Specialty Active Pharmaceutical Ingredients Market Size by Application
        7.2.1 Europe Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2028)
        7.2.2 Europe Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2028)
    7.3 Europe Specialty Active Pharmaceutical Ingredients Market Size by Country
        7.3.1 Europe Specialty Active Pharmaceutical Ingredients Sales by Country (2017-2028)
        7.3.2 Europe Specialty Active Pharmaceutical Ingredients Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Size by Type
        8.1.1 Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2028)
        8.1.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2028)
    8.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Size by Application
        8.2.1 Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2028)
        8.2.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2028)
    8.3 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Size by Region
        8.3.1 Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region (2017-2028)
        8.3.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Specialty Active Pharmaceutical Ingredients Market Size by Type
        9.1.1 Latin America Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2028)
        9.1.2 Latin America Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2028)
    9.2 Latin America Specialty Active Pharmaceutical Ingredients Market Size by Application
        9.2.1 Latin America Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2028)
        9.2.2 Latin America Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2028)
    9.3 Latin America Specialty Active Pharmaceutical Ingredients Market Size by Country
        9.3.1 Latin America Specialty Active Pharmaceutical Ingredients Sales by Country (2017-2028)
        9.3.2 Latin America Specialty Active Pharmaceutical Ingredients Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Size by Type
        10.1.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2028)
    10.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Size by Application
        10.2.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2028)
    10.3 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Size by Country
        10.3.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Sanofi
        11.1.1 Sanofi Corporation Information
        11.1.2 Sanofi Overview
        11.1.3 Sanofi Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Sanofi Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sanofi Recent Developments
    11.2 Cambrex
        11.2.1 Cambrex Corporation Information
        11.2.2 Cambrex Overview
        11.2.3 Cambrex Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Cambrex Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Cambrex Recent Developments
    11.3 Almac
        11.3.1 Almac Corporation Information
        11.3.2 Almac Overview
        11.3.3 Almac Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Almac Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Almac Recent Developments
    11.4 Johnson Matthey
        11.4.1 Johnson Matthey Corporation Information
        11.4.2 Johnson Matthey Overview
        11.4.3 Johnson Matthey Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Johnson Matthey Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Johnson Matthey Recent Developments
    11.5 PolyPeptide
        11.5.1 PolyPeptide Corporation Information
        11.5.2 PolyPeptide Overview
        11.5.3 PolyPeptide Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 PolyPeptide Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 PolyPeptide Recent Developments
    11.6 AmbioPharm
        11.6.1 AmbioPharm Corporation Information
        11.6.2 AmbioPharm Overview
        11.6.3 AmbioPharm Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 AmbioPharm Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 AmbioPharm Recent Developments
    11.7 Avecia
        11.7.1 Avecia Corporation Information
        11.7.2 Avecia Overview
        11.7.3 Avecia Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Avecia Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Avecia Recent Developments
    11.8 ST Pharm
        11.8.1 ST Pharm Corporation Information
        11.8.2 ST Pharm Overview
        11.8.3 ST Pharm Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 ST Pharm Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 ST Pharm Recent Developments
    11.9 Biospring
        11.9.1 Biospring Corporation Information
        11.9.2 Biospring Overview
        11.9.3 Biospring Specialty Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Biospring Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Biospring Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Specialty Active Pharmaceutical Ingredients Industry Chain Analysis
    12.2 Specialty Active Pharmaceutical Ingredients Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Specialty Active Pharmaceutical Ingredients Production Mode & Process
    12.4 Specialty Active Pharmaceutical Ingredients Sales and Marketing
        12.4.1 Specialty Active Pharmaceutical Ingredients Sales Channels
        12.4.2 Specialty Active Pharmaceutical Ingredients Distributors
    12.5 Specialty Active Pharmaceutical Ingredients Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Specialty Active Pharmaceutical Ingredients Industry Trends
    13.2 Specialty Active Pharmaceutical Ingredients Market Drivers
    13.3 Specialty Active Pharmaceutical Ingredients Market Challenges
    13.4 Specialty Active Pharmaceutical Ingredients Market Restraints
14 Key Findings in The Global Specialty Active Pharmaceutical Ingredients Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Steroidal API
    Table 3. Major Manufacturers of Peptide API
    Table 4. Major Manufacturers of Carbohydrate API
    Table 5. Major Manufacturers of Small Molecule API
    Table 6. Major Manufacturers of High Potency AP
    Table 7. Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Specialty Active Pharmaceutical Ingredients Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Specialty Active Pharmaceutical Ingredients Sales by Region (2017-2022) & (K MT)
    Table 10. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2017-2022)
    Table 11. Global Specialty Active Pharmaceutical Ingredients Sales by Region (2023-2028) & (K MT)
    Table 12. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2023-2028)
    Table 13. Global Specialty Active Pharmaceutical Ingredients Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2017-2022)
    Table 15. Global Specialty Active Pharmaceutical Ingredients Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2023-2028)
    Table 17. Global Specialty Active Pharmaceutical Ingredients Sales by Manufacturers (2017-2022) & (K MT)
    Table 18. Global Specialty Active Pharmaceutical Ingredients Sales Share by Manufacturers (2017-2022)
    Table 19. Global Specialty Active Pharmaceutical Ingredients Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2017-2022)
    Table 21. Specialty Active Pharmaceutical Ingredients Price by Manufacturers (2017-2022) &(USD/MT)
    Table 22. Global Specialty Active Pharmaceutical Ingredients Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Specialty Active Pharmaceutical Ingredients by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Active Pharmaceutical Ingredients as of 2021)
    Table 24. Specialty Active Pharmaceutical Ingredients Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Specialty Active Pharmaceutical Ingredients Product Offered
    Table 26. Date of Manufacturers Enter into Specialty Active Pharmaceutical Ingredients Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)
    Table 29. Global Specialty Active Pharmaceutical Ingredients Sales by Type (2023-2028) & (K MT)
    Table 30. Global Specialty Active Pharmaceutical Ingredients Sales Share by Type (2017-2022)
    Table 31. Global Specialty Active Pharmaceutical Ingredients Sales Share by Type (2023-2028)
    Table 32. Global Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Specialty Active Pharmaceutical Ingredients Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Type (2017-2022)
    Table 35. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Type (2023-2028)
    Table 36. Specialty Active Pharmaceutical Ingredients Price by Type (2017-2022) & (USD/MT)
    Table 37. Global Specialty Active Pharmaceutical Ingredients Price Forecast by Type (2023-2028) & (USD/MT)
    Table 38. Global Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)
    Table 39. Global Specialty Active Pharmaceutical Ingredients Sales by Application (2023-2028) & (K MT)
    Table 40. Global Specialty Active Pharmaceutical Ingredients Sales Share by Application (2017-2022)
    Table 41. Global Specialty Active Pharmaceutical Ingredients Sales Share by Application (2023-2028)
    Table 42. Global Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Specialty Active Pharmaceutical Ingredients Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Application (2017-2022)
    Table 45. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Application (2023-2028)
    Table 46. Specialty Active Pharmaceutical Ingredients Price by Application (2017-2022) & (USD/MT)
    Table 47. Global Specialty Active Pharmaceutical Ingredients Price Forecast by Application (2023-2028) & (USD/MT)
    Table 48. North America Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)
    Table 49. North America Specialty Active Pharmaceutical Ingredients Sales by Type (2023-2028) & (K MT)
    Table 50. North America Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Specialty Active Pharmaceutical Ingredients Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)
    Table 53. North America Specialty Active Pharmaceutical Ingredients Sales by Application (2023-2028) & (K MT)
    Table 54. North America Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Specialty Active Pharmaceutical Ingredients Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Specialty Active Pharmaceutical Ingredients Sales by Country (2017-2022) & (K MT)
    Table 57. North America Specialty Active Pharmaceutical Ingredients Sales by Country (2023-2028) & (K MT)
    Table 58. North America Specialty Active Pharmaceutical Ingredients Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Specialty Active Pharmaceutical Ingredients Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)
    Table 61. Europe Specialty Active Pharmaceutical Ingredients Sales by Type (2023-2028) & (K MT)
    Table 62. Europe Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Specialty Active Pharmaceutical Ingredients Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)
    Table 65. Europe Specialty Active Pharmaceutical Ingredients Sales by Application (2023-2028) & (K MT)
    Table 66. Europe Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Specialty Active Pharmaceutical Ingredients Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Specialty Active Pharmaceutical Ingredients Sales by Country (2017-2022) & (K MT)
    Table 69. Europe Specialty Active Pharmaceutical Ingredients Sales by Country (2023-2028) & (K MT)
    Table 70. Europe Specialty Active Pharmaceutical Ingredients Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Specialty Active Pharmaceutical Ingredients Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)
    Table 73. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Type (2023-2028) & (K MT)
    Table 74. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)
    Table 77. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Application (2023-2028) & (K MT)
    Table 78. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region (2017-2022) & (K MT)
    Table 81. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region (2023-2028) & (K MT)
    Table 82. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)
    Table 85. Latin America Specialty Active Pharmaceutical Ingredients Sales by Type (2023-2028) & (K MT)
    Table 86. Latin America Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Specialty Active Pharmaceutical Ingredients Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)
    Table 89. Latin America Specialty Active Pharmaceutical Ingredients Sales by Application (2023-2028) & (K MT)
    Table 90. Latin America Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Specialty Active Pharmaceutical Ingredients Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Specialty Active Pharmaceutical Ingredients Sales by Country (2017-2022) & (K MT)
    Table 93. Latin America Specialty Active Pharmaceutical Ingredients Sales by Country (2023-2028) & (K MT)
    Table 94. Latin America Specialty Active Pharmaceutical Ingredients Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Specialty Active Pharmaceutical Ingredients Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)
    Table 97. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Type (2023-2028) & (K MT)
    Table 98. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)
    Table 101. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Application (2023-2028) & (K MT)
    Table 102. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country (2017-2022) & (K MT)
    Table 105. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country (2023-2028) & (K MT)
    Table 106. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Sanofi Corporation Information
    Table 109. Sanofi Description and Major Businesses
    Table 110. Sanofi Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 111. Sanofi Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Sanofi Recent Developments
    Table 113. Cambrex Corporation Information
    Table 114. Cambrex Description and Major Businesses
    Table 115. Cambrex Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 116. Cambrex Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Cambrex Recent Developments
    Table 118. Almac Corporation Information
    Table 119. Almac Description and Major Businesses
    Table 120. Almac Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 121. Almac Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Almac Recent Developments
    Table 123. Johnson Matthey Corporation Information
    Table 124. Johnson Matthey Description and Major Businesses
    Table 125. Johnson Matthey Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 126. Johnson Matthey Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Johnson Matthey Recent Developments
    Table 128. PolyPeptide Corporation Information
    Table 129. PolyPeptide Description and Major Businesses
    Table 130. PolyPeptide Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 131. PolyPeptide Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. PolyPeptide Recent Developments
    Table 133. AmbioPharm Corporation Information
    Table 134. AmbioPharm Description and Major Businesses
    Table 135. AmbioPharm Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 136. AmbioPharm Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. AmbioPharm Recent Developments
    Table 138. Avecia Corporation Information
    Table 139. Avecia Description and Major Businesses
    Table 140. Avecia Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 141. Avecia Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Avecia Recent Developments
    Table 143. ST Pharm Corporation Information
    Table 144. ST Pharm Description and Major Businesses
    Table 145. ST Pharm Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 146. ST Pharm Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. ST Pharm Recent Developments
    Table 148. Biospring Corporation Information
    Table 149. Biospring Description and Major Businesses
    Table 150. Biospring Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 151. Biospring Specialty Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Biospring Recent Developments
    Table 153. Key Raw Materials Lists
    Table 154. Raw Materials Key Suppliers Lists
    Table 155. Specialty Active Pharmaceutical Ingredients Distributors List
    Table 156. Specialty Active Pharmaceutical Ingredients Customers List
    Table 157. Specialty Active Pharmaceutical Ingredients Market Trends
    Table 158. Specialty Active Pharmaceutical Ingredients Market Drivers
    Table 159. Specialty Active Pharmaceutical Ingredients Market Challenges
    Table 160. Specialty Active Pharmaceutical Ingredients Market Restraints
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Specialty Active Pharmaceutical Ingredients Product Picture
    Figure 3. Global Specialty Active Pharmaceutical Ingredients Market Share by Type in 2021 & 2028
    Figure 3. Steroidal API Product Picture
    Figure 4. Peptide API Product Picture
    Figure 5. Carbohydrate API Product Picture
    Figure 6. Small Molecule API Product Picture
    Figure 7. High Potency AP Product Picture
    Figure 8. Global Specialty Active Pharmaceutical Ingredients Market Share by Application in 2021 & 2028
    Figure 9. CNS
    Figure 10. Cardiovascular
    Figure 11. Genitourinary/Hormonal Drugs
    Figure 12. Rheumatology
    Figure 13. Diabetes
    Figure 14. Oncology
    Figure 15. Others
    Figure 16. Specialty Active Pharmaceutical Ingredients Report Years Considered
    Figure 17. Global Specialty Active Pharmaceutical Ingredients Sales 2017-2028 (K MT)
    Figure 18. Global Specialty Active Pharmaceutical Ingredients Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 19. Global Specialty Active Pharmaceutical Ingredients Revenue 2017-2028 (US$ Million)
    Figure 20. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 21. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2017-2022)
    Figure 22. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2023-2028)
    Figure 23. North America Specialty Active Pharmaceutical Ingredients Sales YoY (2017-2028) & (K MT)
    Figure 24. North America Specialty Active Pharmaceutical Ingredients Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Specialty Active Pharmaceutical Ingredients Sales YoY (2017-2028) & (K MT)
    Figure 26. Europe Specialty Active Pharmaceutical Ingredients Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Specialty Active Pharmaceutical Ingredients Sales YoY (2017-2028) & (K MT)
    Figure 28. Asia-Pacific Specialty Active Pharmaceutical Ingredients Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Latin America Specialty Active Pharmaceutical Ingredients Sales YoY (2017-2028) & (K MT)
    Figure 30. Latin America Specialty Active Pharmaceutical Ingredients Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. Middle East & Africa Specialty Active Pharmaceutical Ingredients Sales YoY (2017-2028) & (K MT)
    Figure 32. Middle East & Africa Specialty Active Pharmaceutical Ingredients Revenue YoY (2017-2028) & (US$ Million)
    Figure 33. The Specialty Active Pharmaceutical Ingredients Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 34. The Top 5 and 10 Largest Manufacturers of Specialty Active Pharmaceutical Ingredients in the World: Market Share by Specialty Active Pharmaceutical Ingredients Revenue in 2021
    Figure 35. Global Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 36. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2028)
    Figure 37. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2028)
    Figure 38. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2028)
    Figure 39. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2017-2028)
    Figure 40. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2028)
    Figure 41. North America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2028)
    Figure 42. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2028)
    Figure 43. North America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2017-2028)
    Figure 44. North America Specialty Active Pharmaceutical Ingredients Sales Share by Country (2017-2028)
    Figure 45. North America Specialty Active Pharmaceutical Ingredients Revenue Share by Country (2017-2028)
    Figure 46. U.S. Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 47. Canada Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 48. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2028)
    Figure 49. Europe Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2028)
    Figure 50. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2028)
    Figure 51. Europe Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2017-2028)
    Figure 52. Europe Specialty Active Pharmaceutical Ingredients Sales Share by Country (2017-2028)
    Figure 53. Europe Specialty Active Pharmaceutical Ingredients Revenue Share by Country (2017-2028)
    Figure 54. Germany Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 55. France Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 56. U.K. Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 57. Italy Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 58. Russia Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 59. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2028)
    Figure 60. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2028)
    Figure 61. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2028)
    Figure 62. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2017-2028)
    Figure 63. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Share by Region (2017-2028)
    Figure 64. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Share by Region (2017-2028)
    Figure 65. China Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 66. Japan Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 67. South Korea Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 68. India Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 69. Australia Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 70. Taiwan Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 71. Indonesia Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 72. Thailand Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 73. Malaysia Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 74. Philippines Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 75. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2028)
    Figure 76. Latin America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2028)
    Figure 77. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2028)
    Figure 78. Latin America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2017-2028)
    Figure 79. Latin America Specialty Active Pharmaceutical Ingredients Sales Share by Country (2017-2028)
    Figure 80. Latin America Specialty Active Pharmaceutical Ingredients Revenue Share by Country (2017-2028)
    Figure 81. Mexico Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 82. Brazil Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 83. Argentina Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 84. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2028)
    Figure 85. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2028)
    Figure 86. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2028)
    Figure 87. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2017-2028)
    Figure 88. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Share by Country (2017-2028)
    Figure 89. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Share by Country (2017-2028)
    Figure 90. Turkey Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 91. Saudi Arabia Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 92. U.A.E Specialty Active Pharmaceutical Ingredients Revenue (2017-2028) & (US$ Million)
    Figure 93. Specialty Active Pharmaceutical Ingredients Value Chain
    Figure 94. Specialty Active Pharmaceutical Ingredients Production Process
    Figure 95. Channels of Distribution
    Figure 96. Distributors Profiles
    Figure 97. Bottom-up and Top-down Approaches for This Report
    Figure 98. Data Triangulation
    Figure 99. Key Executives Interviewed